Latest news

Acquisition of Voluntis’ shares by AptarGroup,Inc

Voluntis on receiving FDA 510(K) Clearance and expanding

Voluntis on receiving the CE Mark for Oleena

Voluntis expanding their global pharma collaborations

Voluntis announces issuance of a European patent for the intelligent patient support in drug dosing with its Theraxium digital therapeutic…

Transfer of Voluntis shares to the Euronext Growth Paris market as of February 17, 2021

Debiopharm invests in DTx leader Voluntis